Oxy-210

N/A

Report date: 2026/03/30 20:02:02
NME

Base Information

Drug NameOxy-210
Drug Alias NameOxy-210Oxy210
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta inhibitorsHedgehog cell-signalling pathway inhibitorsToll like receptor 4 inhibitors +[5] 
TargetsTransforming growth factor betaToll like receptor 4Toll like receptor 2
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Metabolic Dysfunction-Associated Steatotic Liver DiseaseNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMAX BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesTechnomark Life SciencesMAX BioPharma Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Metabolic Dysfunction-Associated Steatotic Liver DiseaseNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A